NO20055708L - Syntetisk gen som koder for humant karsinembryonalt antigen og anvendelser derav - Google Patents
Syntetisk gen som koder for humant karsinembryonalt antigen og anvendelser deravInfo
- Publication number
- NO20055708L NO20055708L NO20055708A NO20055708A NO20055708L NO 20055708 L NO20055708 L NO 20055708L NO 20055708 A NO20055708 A NO 20055708A NO 20055708 A NO20055708 A NO 20055708A NO 20055708 L NO20055708 L NO 20055708L
- Authority
- NO
- Norway
- Prior art keywords
- cea
- gene encoding
- embryonic antigen
- encoding human
- synthetic gene
- Prior art date
Links
- 201000009030 Carcinoma Diseases 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108700005078 Synthetic Genes Proteins 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108020004705 Codon Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 241000701161 unidentified adenovirus Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46797103P | 2003-05-05 | 2003-05-05 | |
| US54361204P | 2004-02-11 | 2004-02-11 | |
| PCT/EP2004/004802 WO2004099247A2 (en) | 2003-05-05 | 2004-05-03 | Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055708D0 NO20055708D0 (no) | 2005-12-02 |
| NO20055708L true NO20055708L (no) | 2006-02-06 |
Family
ID=33436748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055708A NO20055708L (no) | 2003-05-05 | 2005-12-02 | Syntetisk gen som koder for humant karsinembryonalt antigen og anvendelser derav |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070104685A1 (is) |
| EP (1) | EP1622937A2 (is) |
| JP (1) | JP2007523610A (is) |
| KR (1) | KR20060003903A (is) |
| CN (1) | CN1784424A (is) |
| AU (1) | AU2004235943A1 (is) |
| CA (1) | CA2523720A1 (is) |
| IS (1) | IS8053A (is) |
| NO (1) | NO20055708L (is) |
| NZ (1) | NZ543922A (is) |
| RU (1) | RU2005137697A (is) |
| WO (1) | WO2004099247A2 (is) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2534547A1 (en) * | 2003-08-22 | 2005-03-03 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof |
| JP5148116B2 (ja) * | 2004-02-11 | 2013-02-20 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ | 癌胎児性抗原融合タンパク質及びその使用 |
| JP4881623B2 (ja) * | 2006-01-27 | 2012-02-22 | シスメックス株式会社 | Ｃｅａ核酸増幅用プライマー、プライマーセット、及びがんの診断支援方法 |
| WO2007090596A1 (en) * | 2006-02-06 | 2007-08-16 | Medizinische Universität Wien | Vaccine and antigen mimotopes against cancerous diseases associated with the carcinoembryonic antigen cea |
| EP3539567A1 (en) | 2007-07-02 | 2019-09-18 | Etubics Corporation | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| AU2008281013B2 (en) * | 2007-07-27 | 2012-06-28 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
| WO2009117656A2 (en) * | 2008-03-21 | 2009-09-24 | Vectorlogics,Inc. | Capsid-incorporated antigen for novel adenovirus vaccine |
| KR101815322B1 (ko) * | 2010-01-12 | 2018-01-05 | 서울대학교산학협력단 | 항암 펩타이드 서열 |
| US9605276B2 (en) * | 2012-08-24 | 2017-03-28 | Etubics Corporation | Replication defective adenovirus vector in vaccination |
| ES2795833T3 (es) | 2015-01-09 | 2020-11-24 | Etubics Corp | Composiciones para la vacunación contra el virus del Ebola |
| KR102193635B1 (ko) | 2015-01-09 | 2020-12-21 | 이투빅스 코포레이션 | 복합 면역요법을 위한 방법 및 조성물 |
| US11149087B2 (en) | 2015-04-20 | 2021-10-19 | Etubics Corporation | Methods and compositions for combination immunotherapy |
| CA3115658A1 (en) * | 2018-10-12 | 2020-05-22 | Children's Hospital Medical Center | Modular expression systems for gene expression and methods of using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795737A (en) * | 1994-09-19 | 1998-08-18 | The General Hospital Corporation | High level expression of proteins |
| DE10055545A1 (de) * | 2000-11-09 | 2002-07-25 | Deutsches Krebsforsch | Für Expression in Eukaryonten optimierte HPV 16-L1 und HPV 16-L2 kodierende DNA Sequenzen |
-
2004
- 2004-05-03 RU RU2005137697/13A patent/RU2005137697A/ru not_active Application Discontinuation
- 2004-05-03 CN CNA2004800121157A patent/CN1784424A/zh active Pending
- 2004-05-03 AU AU2004235943A patent/AU2004235943A1/en not_active Abandoned
- 2004-05-03 WO PCT/EP2004/004802 patent/WO2004099247A2/en active Application Filing
- 2004-05-03 US US10/555,744 patent/US20070104685A1/en not_active Abandoned
- 2004-05-03 JP JP2006505382A patent/JP2007523610A/ja not_active Withdrawn
- 2004-05-03 KR KR1020057021059A patent/KR20060003903A/ko not_active Application Discontinuation
- 2004-05-03 CA CA002523720A patent/CA2523720A1/en not_active Abandoned
- 2004-05-03 EP EP04739137A patent/EP1622937A2/en not_active Ceased
- 2004-05-03 NZ NZ543922A patent/NZ543922A/en unknown
-
2005
- 2005-09-29 IS IS8053A patent/IS8053A/is unknown
- 2005-12-02 NO NO20055708A patent/NO20055708L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070104685A1 (en) | 2007-05-10 |
| WO2004099247A3 (en) | 2005-02-24 |
| CN1784424A (zh) | 2006-06-07 |
| JP2007523610A (ja) | 2007-08-23 |
| NO20055708D0 (no) | 2005-12-02 |
| NZ543922A (en) | 2008-05-30 |
| CA2523720A1 (en) | 2004-11-18 |
| RU2005137697A (ru) | 2006-05-10 |
| EP1622937A2 (en) | 2006-02-08 |
| WO2004099247A2 (en) | 2004-11-18 |
| IS8053A (is) | 2005-09-29 |
| AU2004235943A1 (en) | 2004-11-18 |
| KR20060003903A (ko) | 2006-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060813L (no) | Syntetisk gen som koder for human epidermalvekstfaktor 2/NEU og andvendelser derav | |
| NO20055708L (no) | Syntetisk gen som koder for humant karsinembryonalt antigen og anvendelser derav | |
| IL177277A0 (en) | Carcinoembryonic antigen fusions proteins and uses thereof | |
| ATE474048T1 (de) | Her2/neu fusionsproteine | |
| CY1121132T1 (el) | ΠΛΗΡΩΣ-ΑΝΘΡΩΠΙΝΑ ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ANTI-vap-1 | |
| DE602004027902D1 (de) | Dna-vakzine gegen tumorwachstum und anwendungsverfahren dafür | |
| IL198012A0 (en) | Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof | |
| NZ746916A (en) | Construction of oncolytic herpes simplex viruses (ohsv) obligate vector and constructs for cancer therapy | |
| WO2002012341A3 (en) | Her-2/neu fusion proteins | |
| WO2002101075A9 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| Kim et al. | Poxviral vectors for cancer immunotherapy | |
| RU2007136026A (ru) | Варианты ил-21 | |
| BR0316158A (pt) | Vacina de vetor adenoviral | |
| NO20062948L (no) | Promotere for ekspresjon i modifisert vaccinia-virus Ankara | |
| WO2023049636A3 (en) | Cancer therapy compositions and uses thereof | |
| ES2329689T3 (es) | Composiciones y procedimientos para el diagnostico de tumores. | |
| Tornesello et al. | Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations | |
| WO2003044161A3 (en) | Gene amplification and overexpression in cancer | |
| HUP0204216A2 (en) | A new use of antibodies as vaccines | |
| Luo et al. | FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice | |
| ATE331796T1 (de) | Rhesus-karzinoembryonales antigen, dieses codierende nukleotide und verwendungen davon | |
| MX2023012707A (es) | Anticuerpos de la proteina inmunorreceptora de celulas t con dominios ig e itim (anti-tigit) y metodos de uso de estos. | |
| WO2003090778A3 (en) | Dna vaccine combined with an inducer of tumor cell apoptosis | |
| DE60226956D1 (de) | Verstärktes krebs-gen wip1 | |
| WO2003103706A3 (en) | IMMUNOGENIC COMPOSITIONS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |